News
Chronic pain alters DNA marking in the brain
Pioneering study reveals association of chronic pain and broad epigenetic changes.
Published: 14 February 2013
The team led by Prof. Laura Stone, a professor at the Faculty of Dentistry and the Alan Edwards Centre for Research on Pain, and Prof. Moshe Szyf, a professor at the Faculty of Medicine鈥檚 Department of Pharmacology and Therapeutics, have discovered a mechanism that embeds the memory of an injury in the way the DNA is marked in the brain by a chemical coating called methyl groups or DNA methylation. The researchers聽including co-authors Maral Tajerian, Sebastian Alvarado, Magali Millecamps, Pascal Vachon, Cecilia Crosby, and
Catherine Bushnell report in the journal聽PLOS One,聽that if the symptoms of chronic pain are attenuated, the abnormal changes in DNA methylation could be reversed.
Research pioneered at 捆绑SM社区 has previously shown that experiences and not solely chemicals alter the way genes are marked epigenetically, impacting our behavior and well-being. DNA methylation, an epigenetic mark on the gene itself, can therefore serve as a 鈥渕emory鈥� of an experience that will alter the way the gene functions long after the original experience is gone.聽 The crucial difference between 鈥済enetic鈥� and 鈥渆pigenetic鈥� causes for disease is that genetic changes are inherited and fixed, while epigenetic changes in contrast are possibly reversible.
The 捆绑SM社区 research is the first to link chronic pain to genome-wide epigenetic changes in the brain. "Injury results in long-term changes to the DNA markings in the brain; our work shows聽 it might be possible to reverse the effects of chronic pain by interventions using either behavioral or pharmacological means that interfere with DNA methylation, says Prof. Szyf. 鈥漁ur findings have the potential to completely alter the way we treat chronic pain.鈥�
In this study, the researchers show that behavioral interventions that reverse chronic pain also remove differences in DNA methylation in the brain.
The team report alterations in global DNA methylation are observed in the prefrontal cortex (PFC) and amygdala of mice many months following injury to a nerve, and that environmental enrichment reduces both the pain and the pathological changes in PFC global methylation. They also found that the total amount of global methylation in the PFC significantly correlates with pain severity.聽
鈥淭hese results suggest that epigenetic modulation mediates chronic pain-related alterations in the central nervous system (CNS), forming a 鈥渕emory trace鈥� for pain in the brain that can be targeted therapeutically, says Stone. Since epigenetics respond to environmental changes, these mechanisms represent a mind-body link between chronic pain and the brain at the genomic level. 鈥淭he implications of this work are wide reaching and may alter the way we think about chronic pain diagnosis, research and treatment鈥�.
鈥淭hese results suggest that epigenetic modulation mediates chronic pain-related alterations in the central nervous system (CNS), forming a 鈥渕emory trace鈥� for pain in the brain that can be targeted therapeutically, says Stone. Since epigenetics respond to environmental changes, these mechanisms represent a mind-body link between chronic pain and the brain at the genomic level. 鈥淭he implications of this work are wide reaching and may alter the way we think about chronic pain diagnosis, research and treatment鈥�.
